Kataoka Yasushi, Ito Chieko, Kawashima Aya, Ishii Miki, Yamashiro Satoko, Harada Kazuki, Ochi Hiroki, Sawada Takuo
Department of Veterinary Microbiology, Nippon Veterinary and Life Science University, Tokyo 180-8602, Japan.
J Vet Med Sci. 2013;75(6):749-53. doi: 10.1292/jvms.12-0243. Epub 2013 Jan 25.
The purpose of the present study was to determine the prevalence of antibiotic-resistant enterococci in dogs and cats subjected to differing antibiotic pressures, and the prevalence of vancomycin resistance genes in isolates from these animals. Enterococci were isolated from fecal samples of 65 healthy dogs and 29 healthy cats brought to animal hospitals, from rectal swabs of 73 puppies and 15 kittens from five breeders and two pet shops, and from fecal samples of 20 dogs and 9 cats that were treated with antibiotics in Nippon Veterinary and Life Science University Animal Medical Center. The rates of resistance to ampicillin among isolates from the kitten-puppy group and healthy dog-cat group were 6.8 and 4.3%, respectively. In contrast, the rates of resistance to ampicillin in enterococci from the treatment group under antibiotic pressure were 37.5%. There was a significant difference between the antibiotic-treated group and the untreated group (P<0.01). Similarly, in the treatment group, the rate of resistance to enrofloxacin was extremely high (75.0%). In comparison, in the healthy group and kitten-puppy group, the rates of resistance to enrofloxacin were 23.4 and 12.1%, respectively. Among these groups, a significant difference was also observed in the apparent resistance rates (P<0.01). Vancomycin-resistant enterococci (VRE) harboring vanA or vanB were not detected in any groups. Therefore, contamination of VRE in dogs and cats is still considered to be minimal in Japan.
本研究的目的是确定处于不同抗生素压力下的犬猫中耐抗生素肠球菌的流行情况,以及这些动物分离株中万古霉素耐药基因的流行情况。从被带到动物医院的65只健康犬和29只健康猫的粪便样本、来自五个繁殖者和两家宠物店的73只幼犬和15只小猫的直肠拭子,以及在日本兽医和生命科学大学动物医学中心接受抗生素治疗的20只犬和9只猫的粪便样本中分离出肠球菌。幼犬-小猫组和健康犬-猫组分离株对氨苄西林的耐药率分别为6.8%和4.3%。相比之下,处于抗生素压力下的治疗组肠球菌对氨苄西林的耐药率为37.5%。抗生素治疗组和未治疗组之间存在显著差异(P<0.01)。同样,在治疗组中,对恩诺沙星的耐药率极高(75.0%)。相比之下,在健康组和幼犬-小猫组中,对恩诺沙星的耐药率分别为23.4%和12.1%。在这些组中,表观耐药率也观察到显著差异(P<0.01)。在任何组中均未检测到携带vanA或vanB的万古霉素耐药肠球菌(VRE)。因此,在日本,犬猫中VRE的污染仍被认为是极少的。